左乙拉西坦、丙戊酸钠、苯巴比妥预防大鼠反复热性惊厥疗效观察

程敏; 黄志; 李思秀

PDF(937 KB)

中国当代儿科杂志 ›› 2010, Vol. 12 ›› Issue (07) : 573-575.

论著·实验研究

左乙拉西坦、丙戊酸钠、苯巴比妥预防大鼠反复热性惊厥疗效观察

程敏，黄志，李思秀

作者信息 +

Prophylactic efficacy of levetiracetam, valproate or phenobarbital on febrile convulsions in rats

CHENG Min, HUANG Zhi, LI Si-Xiu

Author information +

文章历史 +

摘要

目的：比较左乙拉西坦、丙戊酸钠、苯巴比妥对大鼠反复热性惊厥的预防作用的差异，指导临床选药。方法：60只Wistar大鼠，随机分为4组，分别每日灌服左乙拉西坦（200 mg/kg）、丙戊酸钠（250 mg/kg）、苯巴比妥（30 mg/kg）及生理盐水（8 mL/kg）。连续灌服5 d后，用热水浴（45℃）诱导热性惊厥，观察其热性惊厥潜伏期、惊厥持续时间、惊厥严重程度改变情况。结果：大鼠用药后，3个药物干预组惊厥潜伏期延长、惊厥持续时间缩短，惊厥严重程度也明显减轻，与对照组比较差异有统计学意义（P＜0.05或0.01），其中苯巴比妥组惊厥持续时间最短，惊厥严重程度最轻；左乙拉西坦组与丙戊酸钠组差异无统计学意义。结论：左乙拉西坦与丙戊酸钠、苯巴比妥比较均能有效预防大鼠反复热性惊厥，其中苯巴比妥疗效较好，左乙拉西坦与丙戊酸钠疗效无差异。［中国当代儿科杂志，2010，12（7）：573-575］

Abstract

OBJECTIVE: To study and compare the prophylatic efficacy of levetiracetam, valproate and phenobarbital on febrile convulsions in rats. METHODS: Sixty Wistar rats were randomly administered with levetiracetam (200 mg/kg), valproate (250 mg/kg), phenobarbital (30 mg/kg) or normal saline (8 ml/kg) for 5 days. Five days later, febrile convulsions were induced by hyperthermal bath (45℃). The latency, duration and the severity of seizures were observed. RESULTS: In all the three drug-treated groups, the latency was significantly prolonged, and the duration and the severity of seizures were notably reduced compared with the saline group（P< 0.05 or 0.01）. The phenobarbital group had the shortest duration of seizures and the least severe seizures among the three drug-treated groups. There were no significant differences between the levetiracetam and valproate groups. CONCLUSIONS: Continuous administration of levetiracetam, valproate or phenobarbital is effective in preventing recurrent febrile convulsions in rats. Phenobarbital appears to be more effective than levetiracetam and valproate. There were no significant differences in the prophylactic efficacy between levetiracetam and valproate.［Chin J Contemp Pediatr, 2010, 12 (7):573-575］

导出引用

程敏, 黄志, 李思秀. 左乙拉西坦、丙戊酸钠、苯巴比妥预防大鼠反复热性惊厥疗效观察[J]. 中国当代儿科杂志. 2010, 12(07): 573-575

CHENG Min, HUANG Zhi, LI Si-Xiu. Prophylactic efficacy of levetiracetam, valproate or phenobarbital on febrile convulsions in rats[J]. Chinese Journal of Contemporary Pediatrics. 2010, 12(07): 573-575

中图分类号： R-33

参考文献

［1］常杏芝，秦炯，吴希如. 幼年大鼠反复热性惊厥脑损伤的研究［J］. 中国当代儿科杂志，2002，4（6）：439-442.
［2］黄志，李娟.三种抗癫癎药物预防动物热性惊厥的比较研究［J］.华南国防医学杂志，2006，20（2）：12-14.
［3］黄志，蔡方成，张小萍. 托吡酯预防FC的临床及实验研究［J］. 第三军医大学学报，2004，26(2)：155-158.
［4］程敏，黄志，李思秀. 左乙拉西坦预防动物热性惊厥的试验研究［J］.儿科药学杂志，2009，15（4）:16-18.
［5］Jiang W, Duong TM, Lanerolle NC. The neuropathology of hyperthermic seizures in the rats［J］. Epilepsia, 1999, 40(1):5-19.
［6］Patsalos PN. Pharmacokinetic profile of levetiracetam : toward ideal characteristics ［J］. Pharmacol Ther, 2000, 85(2):77-85.
［7］Tong X, Patsalos PN. A microdialysis study of the novel antiepileptic drug levetiracetam: extracellular pharmacokinetics and effect on taurine in rat brain ［J］. Br J Pharmacol, 2001, 133(6):867-874.
［8］Brockm-ller J, Thomsen T, Wittstock M, Coupez R, Lochs H, Roots I. Pharmacokinetics of levitiracetam in patients with moderate to severe liver cirrhosis (Child-Pugh classes A.B and C): characterization by dynamic liver function tests ［J］. Clin Pharmacol Ther, 2005, 77(6):529-541.
［9］Zona C, Niespodziany I, Marchetti C, Klitgaard H, Bernardi G, Margineanu DG. Levitiracetam does not modulate neuronal voltage-gated Na+ and T-type Ca2+ currents ［J］. Seizure, 2001, 10(4):279-286.
［10］Klitgaard H. Levetiracetam: the preclinical profile of a new class of antiepileptic drugs? ［J］. Epilepsia, 2001, 42 (Suppl 4):13-18.
［11］Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam ［J］.Proc Natl Acad Sci USA, 2004, 101(26):9861-9866.
［12］Niespodziany I, Klitgaard H, Margineanu DG. Levetiracetam inhibits the high-voltage-activated Ca2+ current in pyramidal near ones of rat hippocampal slices ［J］. Neurosci Leet, 2001, 306 (1-2):5-8.
［13］Nagarkatti N, Deshpande LS, DeLorenzo RJ. Levetiracetam inhibits both ryanodine and IP3 receptor activated calcium induced calcium release in hippocampal neurons in culture ［J］. Neurosci Lett, 2008, 436(3):289-293.